Gradient Investments LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1542265 ARDEN HILLS, MN

Position in VRTX

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$18,636,793

-$1,127,436 QoQ

Shares Held

41,736

-4.3% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.55%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gradient Investments LLC holds $2,903,408 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	16,437	$1,286,523
2	ACAD	Acadia Pharmaceuticals Inc	32,738	$828,271
3	REGN	Regeneron Pharmaceuticals, Inc.	827	$515,667
4	ORKA	Oruka Therapeutics, Inc.	2,868	$272,947

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,636,793	41,736	-4.3%	Shares	Sole	2026-04-13
2025-12-31	$19,764,229	43,595	+6.4%	Shares	Sole	2026-01-08
2025-09-30	$16,048,232	40,977	+7.8%	Shares	Sole	2025-10-06
2025-06-30	$16,923,387	38,013	+99934.2%	Shares	Sole	2025-07-08
2024-06-30	$17,811	38	0.0%	Shares	Sole	2024-07-18
2024-03-31	$15,884	38	-75.3%	Shares	Sole	2024-04-23
2023-12-31	$62,661	154	-14.0%	Shares	Sole	2024-01-18
2023-09-30	$62,245	179	+713.6%	Shares	Sole	2023-10-27
2023-06-30	$7,742	22	+83.3%	Shares	Sole	2023-07-11
2023-03-31	$3,780	12	+71.4%	Shares	Sole	2023-04-17
2022-12-31	$2,021	7	+133.3%	Shares	Sole	2023-01-10
2021-09-30	$544	3	-85.7%	Shares	Sole	2021-10-18
2021-06-30	$4,234	21	-19.2%	Shares	Sole	2021-07-12
2021-03-31	$5,587	26	-99.2%	Shares	Sole	2021-04-21
2020-12-31	$789,611	3,341	-3.3%	Shares	Sole	2021-01-08
2020-09-30	$939,902	3,454	-47.3%	Shares	Sole	2020-10-06
2020-06-30	$1,901,530	6,550	-13.1%	Shares	Sole	2020-07-10
2020-03-31	$1,793,905	7,539	—	Shares	Sole	2020-04-07
No filing history on record for this holder in this stock.